Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling

Sorafenib, a small inhibitor of tyrosine protein kinases, is currently the standard chemotherapy drug for the treatment of advanced hepatocellular carcinoma (HCC). Although sorafenib improves the survival of HCC patients, its efficacy is not optimal and requires further improvement. Capsaicin, the m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Acta Pharmacol Sin
Egile Nagusiak: Zhang, Su-shan, Ni, Yu-hao, Zhao, Chen-ru, Qiao, Zhen, Yu, Hong-xia, Wang, Lu-yao, Sun, Jin-yan, Du, Chen, Zhang, Jia-hao, Dong, Li-ying, Wang, KeWei, Gao, Jian-jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5843835/
https://ncbi.nlm.nih.gov/pubmed/29188798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.156
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak